Next Article in Journal
Efficacy and Safety of Botulinum Toxin Type A on Persistent Myofascial Pain: A Randomized Clinical Trial
Previous Article in Journal
OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays
Previous Article in Special Issue
A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients
Open AccessEditorial

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction

Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, and Tzu Chi University, Hualien 970, Taiwan
Toxins 2020, 12(6), 394; https://doi.org/10.3390/toxins12060394
Received: 11 June 2020 / Accepted: 12 June 2020 / Published: 14 June 2020
Note: In lieu of an abstract, this is an excerpt from the first page.

Botulinum toxin A (BoNT-A) is a potent protein that can selectively modulate neurotransmission from nerve endings, resulting in the blocking of neurotransmitter releases and causing muscular paralysis [...] View Full-Text
Keywords: botulinum toxin; functional urological disorders; pain; inflammation; overactive bladder; neurogenic detrusor overactivity; interstitial cystitis; chronic pelvic pain syndrome botulinum toxin; functional urological disorders; pain; inflammation; overactive bladder; neurogenic detrusor overactivity; interstitial cystitis; chronic pelvic pain syndrome
MDPI and ACS Style

Kuo, H.-C. Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction. Toxins 2020, 12, 394.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop